News
Could our nose cells be key to preventing future pandemic spread?
6+ hour, 22+ min ago (534+ words) Deadly respiratory viruses, like those causing COVID-19 and flu, spread among people through a simple act: breathing. With each inhalation, these airborne pathogens enter the body through our noses, throat and lungs, and replicate in the infected person before being…...
Could cells in our nose be key to preventing future pandemic spread?
6+ hour, 52+ min ago (536+ words) Securing the Future: CEPI 3. 0 Investment Case Deadly respiratory viruses, like those causing COVID-19 and flu, spread among people through a simple act: breathing. With each inhalation, these airborne pathogens enter the body through our noses, throat and lungs, and replicate…...
Platform technologies: Accelerating vaccine development and production
2+ week, 2+ day ago (279+ words) Credit: University of Queensland CEPI's long-term goal is to make sure that a range of proven platforms is readily available to lower and middle-income countries, so that effective disease defences can be developed and deployed for outbreak response within 100 days…...
CEPI launches global plan to secure the future against epidemic and pandemic threats
1+ mon, 3+ week ago (327+ words) OSLO, 13 FEB'As deadly disease outbreaks become ever more frequent and disruptive, CEPI (the Coalition for Epidemic Preparedness Innovations) is setting out a bold plan to transform the way the world tackles the most dangerous viral threats. The new five-year strategy'CEPI…...
Preparing today for tomorrow's Lassa fever vaccines
2+ mon, 6+ day ago (348+ words) With the prospect of protection against Lassa fever closer than ever before, CEPI and the West African Health Organization (WAHO) today launched the first end-to-end access roadmap for Lassa fever vaccines. This roadmap sets out a coordinated pathway to ensure…...
University of Oxford launches world's first Phase II Nipah virus vaccine trial
4+ mon, 1+ day ago (790+ words) 9 December 2025. OXFORD, UK. The University of Oxford has launched the world's first Phase II clinical trial of a Nipah virus vaccine candidate." The trial, conducted in Bangladesh in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b), and…...
CEPI, Oxford, Serum create largest-ever reserve of investigational Rift Valley fever vaccine
2+ mon, 3+ week ago (268+ words) In a major milestone for rapid vaccine production, SII has already filled and labelled 12, 000 vials of the Ch Ad Ox1 RVF vaccine just 16 days after receiving the essential ingredients. Ch Ad Ox1 RVF is among the most advanced vaccine candidates being developed…...